Australia markets closed

Atea Pharmaceuticals, Inc. (AVIR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.0400+0.0400 (+1.00%)
At close: 04:00PM EDT
3.9100 -0.13 (-3.22%)
After hours: 06:49PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 340.02M
Enterprise value -235.68M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.61
Enterprise value/revenue 58.97
Enterprise value/EBITDA 1.44

Trading information

Stock price history

Beta (5Y monthly) 0.17
52-week change 320.60%
S&P500 52-week change 327.86%
52-week high 35.1900
52-week low 32.7650
50-day moving average 34.0434
200-day moving average 33.4760

Share statistics

Avg vol (3-month) 3488.95k
Avg vol (10-day) 3532.99k
Shares outstanding 584.16M
Implied shares outstanding 685.06M
Float 863.74M
% held by insiders 19.46%
% held by institutions 167.42%
Shares short (15 Mar 2024) 41.7M
Short ratio (15 Mar 2024) 44.62
Short % of float (15 Mar 2024) 42.62%
Short % of shares outstanding (15 Mar 2024) 42.02%
Shares short (prior month 15 Feb 2024) 41.62M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-11.89%
Return on equity (ttm)-22.74%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -119.59M
Net income avi to common (ttm)-135.96M
Diluted EPS (ttm)-1.6300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)578.11M
Total cash per share (mrq)6.87
Total debt (mrq)2.4M
Total debt/equity (mrq)0.43%
Current ratio (mrq)18.24
Book value per share (mrq)6.65

Cash flow statement

Operating cash flow (ttm)-85.39M
Levered free cash flow (ttm)-9.44M